Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV004692676 | SCV005196410 | uncertain significance | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2024-08-01 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.97+1G>A is a splice donor variant which is only predicted to affect isoform c. This variant is present in three alleles (European Non-Finnish), 0.002656% in gnomAD v2.1.1, and is absent in gnomAD v3.1.2 (mean depth coverage 30x). This variant has been reported in two probands meeting at least one of the RUNX1-phenotypic criteria (PS4_Moderate; PMID: 33075818). In summary, this variant meets the criteria to be classified as a variant of unknown significance. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PS4_Moderate. |
Labcorp Genetics |
RCV001378678 | SCV001576301 | uncertain significance | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2023-09-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1067421). Disruption of this splice site has been observed in individual(s) with acute myeloid leukemia (PMID: 33075818). This variant is present in population databases (rs375131372, gnomAD 0.002%). This sequence change affects a donor splice site in intron 3 of the RUNX1 gene. However, it is currently unclear if variants that occur in this region of the gene cause disease. |